Federica Predolini

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition

Siming Zhao, Stefania Bellone, Salvatore Lopez et al. · Proceedings of the National Academy of Sciences · 2016 · 232 citations · Full text

Medicine, Genetics, Oncology +17

SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Jonathan Black, Gulden Menderes, Stefania Bellone et al. · Molecular Cancer Therapeutics · 2016 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro

Stefania Bellone, Eliana Bignotti, Silvia Lonardi et al. · Gynecologic Oncology · 2016 · 82 citations · Full text

Medicine, Cancer Biology, Oncology +14

Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients

Stefania Bellone, Floriana Centritto, Jonathan Black et al. · Gynecologic Oncology · 2015 · 81 citations

Medicine, Immunology, Oncology +14

SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression

Gulden Menderes, Elena Bonazzoli, Stefania Bellone et al. · Clinical Cancer Research · 2017 · 67 citations

Medicine, Oncology, Pharmacology +17